Terms ending in 2040
Yeda Research and Development Co. Ltd.
Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,540,725 | Systems and Methods for Generating 3D Images Based on Fluorescent Illumination In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 11,480,568 | Diagnosis of Autoimmune Diseases In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 12,559,765 | Compositions and Methods for Regulating Gene Expression for Targeted Mutagenesis In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 11,542,508 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Expressing an Expression Product of Interest In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 11,982,566 | System, Device, and Method for Quantum Correlation Measurement With Single Photon Avalanche Diode Arrays In force · High confidence | Ecole Polytechnique Federale de Lausanne (EPFL) | In force | High confidence | |
| US 10,995,141 | Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease In force · High confidence | Immunobrain Checkpoint, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.